vimarsana.com
Home
Live Updates
Bristol-Myers Squibb Company (NYSE:BMY) Q2 2023 Earnings Call Transcript : comparemela.com
Bristol-Myers Squibb Company (NYSE:BMY) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone. Welcome to the Bristol-Myers Squibb Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode.
Related Keywords
Canada ,
Japan ,
United States ,
Massachusetts ,
Libertyville ,
Illinois ,
Netherlands ,
United Kingdom ,
Germany ,
America ,
Opdivo Hodgkin ,
Timothy Anderson ,
Chris Shibutani ,
Steve Scala ,
Terence Flynn ,
Evan Seigerman ,
Dane Leone ,
David Elkins ,
Chris Boerner ,
Raymond James ,
David Risinger ,
Andrew Baum ,
Christopher Boerner ,
Giovanni Caforio ,
Matthew Phipps ,
Colin Bristow ,
Carter Gould ,
Samit Hirawat ,
Matt Phipps ,
William Blair ,
Geoff Meacham ,
Yihan Li ,
Olivia Brayer ,
Adam Lenkowsky ,
Mohit Bansal ,
Chris Schott ,
Tim Anderson ,
Seamus Fernandez ,
Wells Fargo ,
Cantor Fitzgerald ,
Head Of Global Drug Development ,
Bristol Myers Squibb Company ,
Morgan Stanley ,
Credit Suisse ,
Patient Assistance Foundation ,
Goldman Sachs ,
Barclays ,
Wolfe Research ,
Bristol Myers Squibb Co ,
Bristol Myers Squibb ,
Call Transcript July ,
Myers Squibb Company ,
Bristol Myers Squibb Second Quarter ,
Stim Power ,
Vice President ,
Board Chair ,
Chief Executive Officer ,
Chief Financial ,
Chief Operating Officer ,
Chief Commercialization Officer ,
Chief Medical Officer ,
Global Drug ,
Assistance Foundation ,
Bristol Myers ,
Assistance Foundations ,
Maybei Ll ,
comparemela.com © 2020. All Rights Reserved.